Form EFFECT BIOCRYST PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 9:00 A.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Japan approves BioCryst's Orladeyo for children ages 2 to 12 with HAE
- As New Research Shows Persistent Funding Gaps, The National Network of Black Foundations & Funds Expands Its Public Presence
- Dr. Steven Muscoreil Announces National Scholarship for Future Physicians Committed to Healthcare Innovation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
